Bokaro has witnessed a significant advancement in its healthcare sector with the installation of the state-of-the-art LINAC TrueBeam radiation machine at Medicant Hospital. This cutting-edge technology is set to revolutionize cancer treatment in the region, offering highly precise, safer, and more effective radiation therapy.
The inauguration ceremony was marked by the presence of B.K. Tiwari, Director In-Charge of BSL, SAIL, as the chief guest. Other dignitaries, including Dr. B.B. Karunamayee (CMO, In-Charge of BGH), H.M. Jha (CGM-HR, BSL), Laxmi Das (CGM-Tech, DI Office), Medicant CMD Dr. Majid Ahmed Talikoti, and former MLA Biranchi Narayan, also attended, emphasizing the hospital’s pivotal role in strengthening Bokaro’s medical infrastructure.
Chief Guest DIC- BSL B.K. Tiwari highlighted the hospital’s transformative impact on the region’s healthcare. He stated, "Medicant Hospital is equipped with world-class medical technology and infrastructure. Earlier, patients had to travel to other states for advanced treatment. Now, they can receive the same high-quality care locally, ensuring not only better treatment but also a more comfortable and convenient experience."
The LINAC TrueBeam machine is a globally recognized radiation therapy system designed to target cancer cells with extreme precision while minimizing damage to surrounding healthy tissues. Its introduction at Medicant Hospital is expected to significantly improve cancer care accessibility for patients in Region.
To offer a closer look at its advanced medical facilities, MHRC organized an exclusive tour on Saturday, allowing community members and media representatives to explore its cutting-edge infrastructure. The event provided valuable insights into MHRC’s commitment to excellence in patient care and its vision of making Bokaro a premier healthcare hub.
With this initiative, Medicant Hospital is redefining cancer treatment accessibility in the region, furthering its mission to provide world-class medical services to the people of Jharkhand and beyond.